CWGCX
Price
$65.25
Change
+$1.26 (+1.97%)
Updated
Mar 5 closing price
Net Assets
125.54B
JSLNX
Price
$18.53
Change
+$0.38 (+2.09%)
Updated
Mar 5 closing price
Net Assets
2.88B
Ad is loading...

CWGCX vs JSLNX

Header iconCWGCX vs JSLNX Comparison
Open Charts CWGCX vs JSLNXBanner chart's image
American Funds Capital World Gr&Inc C
Price$65.25
Change+$1.26 (+1.97%)
VolumeN/A
Net Assets125.54B
Janus Henderson Global Select N
Price$18.53
Change+$0.38 (+2.09%)
VolumeN/A
Net Assets2.88B
CWGCX vs JSLNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. JSLNX commentary
Mar 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and JSLNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 126B vs. JSLNX (2.88B). CWGCX pays higher dividends than JSLNX: CWGCX (1.04) vs JSLNX (0.99). CWGCX was incepted earlier than JSLNX: CWGCX (24 years) vs JSLNX (8 years). JSLNX is a more actively managed with annual turnover of: 46.00 vs. CWGCX (27.00). CWGCX has a lower initial minimum investment than JSLNX: CWGCX (250) vs JSLNX (1000000). CWGCX annual gain was more profitable for investors over the last year : 5.88 vs. JSLNX (1.48). CWGCX return over 5 years is better than : 42.39 vs. JSLNX (37.94).
CWGCXJSLNXCWGCX / JSLNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD4.0013.174126%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets126B2.88B4,381%
Annual Yield % from dividends1.040.99106%
Returns for 1 year5.881.48398%
Returns for 3 years19.3812.12160%
Returns for 5 years42.3937.94112%
Returns for 10 years43.88N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUFCX19.39N/A
N/A
PGIM Jennison Financial Services C
DWOAX18.53N/A
N/A
BNY Mellon Research Growth A
CNGLX20.05N/A
N/A
Commonwealth Global
HLMVX34.14N/A
N/A
Harding Loevner Global Equity Inst
HHHSX16.88N/A
N/A
Hartford Schroders Emerging Mkts Eq R4